Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
about
Mitochondrial apoptosis and FAK signaling disruption by a novel histone deacetylase inhibitor, HTPB, in antitumor and antimetastatic mouse modelsComplex structure of a bacterial class 2 histone deacetylase homologue with a trifluoromethylketone inhibitorCockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodelingZinc-chelation contributes to the anti-angiogenic effect of ellagic acid on inhibiting MMP-2 activity, cell migration and tube formationMetastasis suppressor proteins: discovery, molecular mechanisms, and clinical applicationInvasive Cell Fate Requires G1 Cell-Cycle Arrest and Histone Deacetylase-Mediated Changes in Gene ExpressionHistone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions.Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy.Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinomaMetzincin proteases and their inhibitors: foes or friends in nervous system physiology?The silencing of RECK gene is associated with promoter hypermethylation and poor survival in hepatocellular carcinoma.RECK impedes DNA repair by inhibiting the erbB/JAB1/Rad51 signaling axis and enhances chemosensitivity of breast cancer cells.HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma.Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator.MicroRNA-222 regulates MMP-13 via targeting HDAC-4 during osteoarthritis pathogenesis.Histone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migrationmicroRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTENThe homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype.Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cellsHDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells.Targeting histone deacetylases for the treatment of diseaseRNAi and cancer: Implications and applications.Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.Inhibition of histone deacetylases induces formation of multipolar spindles and subsequent p53-dependent apoptosis in nasopharyngeal carcinoma cells.HDAC Inhibitors and RECK Modulate Endoplasmic Reticulum Stress in Tumor Cells.Pattern of RECK CpG methylation as a potential marker for predicting breast cancer prognosis and drug-sensitivity.MicroRNA miR-182 cluster mediated modulation of RECK without changes in cell surface membrane type-1 matrix metalloproteinase (MT1-MMP).Effects of 5-aza-2'deoxycytidine on RECK gene expression and tumor invasion in salivary adenoid cystic carcinoma.Protein kinase D signaling in cancer: A friend or foe?A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugs.HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells.Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitorsEffects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cellsRECK is up-regulated and involved in chondrocyte cloning in human osteoarthritic cartilageHistone Deacetylase Inhibitor Trichostatin a Promotes the Apoptosis of Osteosarcoma Cells through p53 Signaling Pathway Activation.Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model.The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
P2860
Q27310013-C9CCBB31-4AAD-4760-87CA-729507BA6EEDQ27644313-C018EA05-5379-4636-BCCF-7A0B260EE40AQ28245824-2E83C2FE-77B6-4EA9-B975-5D3BC130AB70Q28478040-27CD44F4-686F-4664-B17D-838EA6E97878Q30444715-FFADBE51-0A74-41EA-93EF-E5FD0187B6EBQ30703677-96C0182E-F0ED-4076-B755-F657EEB2C63BQ33705588-20CB8304-E814-488A-BF26-2953DC510EDEQ34488424-02B89B8B-C06F-45E4-84B2-C890F044A340Q34606259-29764860-3165-44EC-9D9C-BACEEB7FEA12Q34768858-AAD4CCFC-AD0C-4058-99C0-088E51B2E7ADQ35828539-F8D9F7E1-F0A4-48F7-B095-5D6AE0FDCD7BQ36057111-7E7E91EC-6120-40F1-A120-2CC4448AA92DQ36099567-575018E8-B477-4A45-B69E-893F51A23C79Q36302249-B6090AC4-9506-4F2E-A950-902C79BF14F8Q36323810-1DAAB884-1073-4AF1-A49B-63A4CF388558Q36608727-5340D4E4-E127-4C75-88EF-1607B7FDB0A6Q36642781-2C2E86E5-69F7-454C-B44B-B8F0221B7F39Q36677702-EC6F00FF-71FB-46F8-9586-9A35F5DEB8A5Q36862051-5EED7823-95F7-40AB-83C6-7B7B3B134A10Q36916322-0DC37306-0D69-4D30-AA4C-5D152E7A015FQ37296159-0B833A5C-B153-4D9F-8E3B-8E3FA0019791Q37331654-1D0234D2-A9C1-4234-A75F-7C31FCB17CCAQ37461694-954D915E-5618-4FC2-B506-3B59A3A46522Q37536821-2DDB4BB0-A519-4984-A92E-F6F579A2A6D2Q37690659-665FA38D-ABE5-4E73-9911-E176F7AA7FCDQ37696099-DFB560BB-679D-4F46-81DC-BD222994413DQ38816478-F4E572EB-2863-4F9E-904D-ABEE9261D211Q38927697-1123BE37-D739-48FA-929F-94E5E897F110Q39348454-88CDB795-F2EC-4C88-AC65-1C1F2125BF6EQ39595777-759D82F3-7B58-4B10-996A-6B78B747E197Q39742798-082617F2-0810-4183-9D38-8E437C243E80Q39879745-906C9256-06AC-4B9A-8590-772CF7119C22Q39910687-19F2B80A-FC8F-49DF-B951-197A77630354Q39956136-02B9D7BE-335B-4B1C-B32E-7F953032D83AQ40792334-F41D016A-6C66-427F-A887-844445D7CBA9Q42364933-0C45A3FB-E3EF-4114-8545-341F62249541Q47157413-F9344DF4-F178-4ECE-8798-205A094D49D5Q55007506-5EF2366A-CA5D-4B68-87B4-08430164AF14Q58792448-6C67EBA6-97AB-468B-829A-BDBF24D9358C
P2860
Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Histone deacetylase inhibitor ...... tion and cancer cell invasion.
@ast
Histone deacetylase inhibitor ...... tion and cancer cell invasion.
@en
Histone deacetylase inhibitor ...... tion and cancer cell invasion.
@nl
type
label
Histone deacetylase inhibitor ...... tion and cancer cell invasion.
@ast
Histone deacetylase inhibitor ...... tion and cancer cell invasion.
@en
Histone deacetylase inhibitor ...... tion and cancer cell invasion.
@nl
prefLabel
Histone deacetylase inhibitor ...... tion and cancer cell invasion.
@ast
Histone deacetylase inhibitor ...... tion and cancer cell invasion.
@en
Histone deacetylase inhibitor ...... tion and cancer cell invasion.
@nl
P2093
P1433
P1476
Histone deacetylase inhibitor ...... ation and cancer cell invasion
@en
P2093
Hui-Chiu Chang
Li-Teh Liu
Lien-Chai Chiang
Wen-Chun Hung
P304
P407
P577
2003-06-01T00:00:00Z